Browse every story filed under this topic, curated from trusted publishers around the world.
Roche has reported new findings from the Phase III METEOROID trial of Enspryng in adults and adolescents with MOGAD. The post Roche reports Phase III METEOROID study results for MOGAD appeared first on Clinical Trials Arena.
Read full story →
The Swiss drugmaker Roche presented the latest data for its experimental multiple sclerosis drug, setting the stage for the company …
The era of off-label guesswork for patients living with the rare autoimmune disorder MOGAD may soon be over, as a …
You've seen all articles for #roche.
Check back
soon
for new stories.